Akhila Rachel James et al. 2023. Identification of Herbacetin as L858R and T790M inhibitor in Breast Cancer. Journal of Population Therapeutics and Clinical Pharmacology. 30, 6 (Apr. 2023), 267–286. DOI:https://doi.org/10.47750/jptcp.2023.30.06.033.